Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	53.03	65.64	42.89
Graham Fair Price	-55.03	14.91	33.16
PEG	1619.14	-0.11	< 0.005
Price/Book	-6.32	0.52	0.55
Price/Cash Flow	236.44	-91.90	27.32
Prices/Earnings	350.92	13.30	-2.95
Price/Sales	-10.51	5.10	5.70
Price/FCF	236.44	-91.90	27.32
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-61.74	0.26	0.67
Operating Margin	-81.02	0.14	-0.76
ROA	-78.65	< 0.005	-0.02
ROE	-0.05	< 0.005	-79.22
ROIC	-0.03	< 0.005	-78.45
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.02	-88.39
Dividends QOQ	< 0.005	-0.01	1454.20
EBIT QOQ	-5.72	1.20	-79.07
EPS QOQ	-4.60	1.21	-73.77
FCF QOQ	-0.06	-1.28	-1921.73
Revenue QOQ	-0.02	0.04	120.81
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	378.42	809.01	113.79
Days Sales Outstanding (DSO)	60.59	43.21	-28.69
Inventory Turnover	0.24	0.11	-53.23
Debt/Capitalization	0.39	0.37	-3.80
Quick Ratio	2.30	1.62	-29.72
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	32.32	31.89	-1.33
Cash	4.28	3.12	-26.97
Capex	-0.09	-0.05	48.43
Free Cash Flow	0.65	-0.18	-72.53
Revenue	3.13	3.23	3.29
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.30	1.78	-22.57
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.44	32.10	65.10
Naive Interpretation	Member

06 - Financial Health · Weak

Rating